# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Baird analyst Eric Coldwell maintains Icon (NASDAQ:ICLR) with a Outperform and raises the price target from $363 to $367.
Full-year 2024 revenue guidance is reaffirmed in the range of $8,480 - $8,720 million, representing a year over year increase o...
Financial OutlookICON is updating its full-year 2024 guidance to incorporate its recent debt refinancing, including the impact ...
ICON plc (NASDAQ:ICLR) ("ICON"), a world-leading healthcare intelligence and clinical research organization, today anno...
TD Cowen analyst Charles Rhyee maintains Icon (NASDAQ:ICLR) with a Buy and raises the price target from $343 to $349.
Evercore ISI Group analyst Ross Muken maintains Icon (NASDAQ:ICLR) with a Outperform and lowers the price target from $350 t...